ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Nevro Corp

Nevro Corp (NVRO)

4.58
0.26
(6.02%)
Closed November 28 4:00PM
4.37
-0.21
(-4.59%)
After Hours: 7:02PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.37
Bid
-
Ask
-
Volume
343,567
4.34 Day's Range 4.61
3.95 52 Week Range 22.64
Market Cap
Previous Close
4.32
Open
4.34
Last Trade Time
Financial Volume
$ 1,558,320
VWAP
4.5357
Average Volume (3m)
539,379
Shares Outstanding
37,471,622
Dividend Yield
-
PE Ratio
-1.87
Earnings Per Share (EPS)
-2.46
Revenue
425.17M
Net Profit
-92.21M

About Nevro Corp

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of lea... Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Nevro Corp is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker NVRO. The last closing price for Nevro was $4.32. Over the last year, Nevro shares have traded in a share price range of $ 3.95 to $ 22.64.

Nevro currently has 37,471,622 shares outstanding. The market capitalization of Nevro is $161.88 million. Nevro has a price to earnings ratio (PE ratio) of -1.87.

Nevro (NVRO) Options Flow Summary

Overall Flow

Bullish

Net Premium

27k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

NVRO Latest News

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches PR Newswire REDWOOD CITY, Calif., Nov. 18...

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif., Nov. 15, 2024 REDWOOD CITY, Calif., Nov. 15, 2024 /PRNewswire/ -- Nevro Corp. (NYSE:...

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally PR Newswire REDWOOD CITY, Calif., Nov. 12, 2024 HFX iQ...

Nevro Reports Third-Quarter 2024 Financial Results

Nevro Reports Third-Quarter 2024 Financial Results PR Newswire REDWOOD CITY, Calif., Nov. 11, 2024 Reaffirms Full-Year 2024 Revenue Guidance and Raises Full-Year 2024 Adjusted EBITDA...

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy PR Newswire REDWOOD CITY, Calif., Oct. 29, 2024 Analysis Marks the First...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1854.420549581844.1854.824.0454957604.40443801CS
4-0.83-15.96153846155.26.853.957956284.84407838CS
12-1.15-20.83333333335.526.853.955393795.07046246CS
26-5.12-53.95152792419.4910.373.956089176.47472647CS
52-11.84-73.041332510816.2122.643.9557748310.75469544CS
156-82.9-94.992551850687.2798.123.9557067332.20123108CS
260-107.95-96.1093304843112.32188.143.9551362666.09278497CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SOSSOS Limited
$ 9.90
(42.45%)
4.11M
DNMRDanimer Scientific Inc
$ 6.00
(30.72%)
85.95k
OPADOfferpad Solutions Inc
$ 4.79
(15.98%)
53.57k
GROVGrove Collaborative Holdings Inc
$ 1.51
(15.27%)
1.12M
YRDYiren Digital Ltd
$ 5.24
(15.16%)
243.22k
PNSTPinstripes Holdings Inc
$ 0.76
(-24.00%)
169.98k
DDD3D Systems Corporation
$ 2.95
(-13.49%)
6.25M
DELLDell Technologies Inc
$ 124.3608
(-12.26%)
37.14M
DOUGDouglas Elliman Inc
$ 2.37
(-11.57%)
1.07M
HPQHP Inc
$ 34.66
(-11.36%)
27.36M
BBDBanco Bradesco SA
$ 2.265
(-4.43%)
69.51M
ACHRArcher Aviation Inc
$ 8.085
(11.98%)
62.74M
NIONIO Inc
$ 4.375
(1.51%)
45.51M
DELLDell Technologies Inc
$ 124.3608
(-12.26%)
38.09M
ABEVAmbev SA
$ 2.145
(-2.05%)
36.09M

NVRO Discussion

View Posts
whytestocks whytestocks 5 years ago
News: $NVRO Here's Why Nevro Stock Bounded Higher on Thursday

Shares of Nevro   (NYSE: NVRO) , a medical device company with a focus on pain management, are soaring in response to a positive third-quarter earnings report. The company reported earnings and revenue that blew past analyst expectations, and raised guidance for the rest of 2019. As a...

Find out more NVRO - Here's Why Nevro Stock Bounded Higher on Thursday
👍️0
joseytheoutlawwales joseytheoutlawwales 5 years ago
New system with both lower frequency ranges and combination therapies, in addition to HF10 (10k Hz) ranges, and brand new patient peripherals (ie, remote, charger, etc) should be out in November I’m told.

Should be interesting.
👍️0
whytestocks whytestocks 6 years ago
News: $NVRO Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10Ȓ...

In case you are interested https://marketwirenews.com/news-releases/nevro-to-highlight-substantial-body-of-clinical-evidence-supporting-expanded-applications-and-unique-capabilities-of-hf10-therapy-at-the-14th-international-neuromodulation-society-world-congress-8248992.html
👍️0
stocktrademan stocktrademan 6 years ago
NVRO buy 61.44



normal chart







log chart






👍️0
KOmani KOmani 6 years ago
Down 14% on no news at all ....

Perhaps a little overdone?
👍️0
jimmybob jimmybob 8 years ago
$NVRO now up 49.3% YTD,closing at another all-time high today,and hitting all-time highs intra-day.. story not over… http://www.optionmillionaires.com/bull-case-nevro-nvro-update/
👍️0
jimmybob jimmybob 8 years ago
The Bull Case on Nevro ( $NVRO ) - Update : http://www.optionmillionaires.com/bull-case-nevro-nvro-update/ $MEDT $STJ $BSX $NURO $ETRM
👍️0
BudFoxWallStreet BudFoxWallStreet 8 years ago
Nevro's Revenue Surges, Lower Than Expected Loss |

https://www.medtechy.com/the-ticker/articles/2016/nevros-revenue-surges-lower-than-expected-loss

👍️0
jimmybob jimmybob 8 years ago
Snapshot on why I have/continue to love $NVRO (CC still going w/ speechless analysts) - http://www.optionmillionaires.com/bull-case-nevro-nvro/

👍️0
jimmybob jimmybob 9 years ago
One of the best growth stories out there, $NVRO revenue up 114% in ’15 looking for 137%+ in ’16

👍️0
jimmybob jimmybob 9 years ago
$NVRO - strong support around $65 , like for new all-time highs before Q1 earnings in May

👍️0
jimmybob jimmybob 9 years ago
Love the breakout on $NVRO friday.. $70+ next

👍️0
BudFoxWallStreet BudFoxWallStreet 9 years ago
Here is Nevro's JP Morgan presentation. They are also presenting at Leerink tomorrow but it is probably the same presentation.

https://www.medtechy.com/boards/companies/nevro/3825

👍️0
jimmybob jimmybob 9 years ago
Key theme from $NVRO @ #JPM16 : ’Expanding Market opportunities’ outside of $1.5 addressable market where its already taking sizable share
👍️0
RealGenius RealGenius 9 years ago
No way 1 billion MC justified here, when not even profitable.
👍️0
quaerere quaerere 9 years ago
Today Nevro submitted and posted a link to their preliminary response to the patent trial and appeals board with reference to the Boston Scientific Corporation challenge to the key Nevro patent.
See http://www.nevro.com/press-release/?r=US&prid=5aa76c3f-164d-4b00-8def-f9ad36ba33b2. I personally, though not a lawyer, was impressed by the strength of the rebuttal.
On another note, I have heard that the first few patients in my state that have received the preliminary trial for effectiveness of the Senza have faired well, and are going to move on to permanent implants. A number of advisory services have not been favorably viewing Nevro, but IMO that is because they are looking at past performance and not considering the game change that FDA approval represents. Others that look at the whole picture, such as Zacks, are very high on NVRO (Rank 1).
Long on NVRO, and added on the recent dip. The sparseness of contributions to this board is an indication that the stock is flying under the radar. I was clued in when the Senza was recommended for my spouse.
👍️0
stocktrademan stocktrademan 9 years ago
$NVRO recent news/filings

bullish

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com

[img]http://charts.stockscores.com/chart.asp?

TickerSymbol=NVRO&TimeRange=400&Interval=d&Volume=1&ChartType=CandleStick&ChartWidth=830&ChartHeight=500&LogSc

ale=None&Band=BB&avgType1=EMA&movAvg1=50&indicator1=MACD&candles=redgreen[/img]

big daily chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

big weekly chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]whclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVRO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVRO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVRO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/news - http://finance.yahoo.com/q/h?s=NVRO

+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVRO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVRO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVRO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C

+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVRO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?

action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVRO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVRO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVRO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVRO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVRO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVRO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVRO+NVROh+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVRO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVRO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVRO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVRO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVRO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVRO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVRO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVRO
Bussinessweek (businessweek.com):

http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVRO
StockTwits (stocktwits.com): http://stocktwits.com/symbol/NVRO

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO
👍️0
uptowndw uptowndw 10 years ago
WTF???? huge jump but on only 2k shares how is this possible?????
👍️0
Penny Roger$ Penny Roger$ 10 years ago
My back hurts. Congrats on IPO $NRVO!

https://www.google.com/finance?q=NVRO

Nevro Corp. is a medical device company focused on developing solutions in the neuromodulation space. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. The Company’s High-frequency spinal cord stimulation (SCS) system, the HF10 SCS, is a spinal cord simulation therapy, which provides electric pulses at a rate of approximately 10,000 Hz for spinal cord stimulation in the treatment of chronic back and leg pain. The electrical pulses are conveyed by small electrodes placed in the epidural space and connected to a battery-powered generator implanted under the skin. The Nevro Senza SCS system is available in Europe and Australia. It is undergoing a pivotal clinical trial, which is intended to collect data to support an application for a Nevro Senza implantable spinal cord stimulation system. The Company’s SENZA-RCT study is intended to evaluate the safety and effectiveness of the Senza SCS system.
👍️0